MIG Capital AG

MIG Capital AG is a Munich-based venture capital firm that invests in early-stage deep tech and life sciences companies across Europe. The firm focuses on sectors such as biopharmaceuticals, medical technology, digital health, energy and environmental technologies, advanced computing, digitalization and IoT, and new materials. MIG Capital has invested over €730 million in more than 50 startups, with a portfolio comprising 33 companies as of 2024.

The firm's investment strategy emphasizes personal support, a strong network, and capital to help founders develop innovative solutions and turn visions into successful businesses. MIG Capital's team consists of engineers, biologists, physicists, lawyers, and investors who actively support the growth of portfolio companies. The firm has realized more than ten successful exits, including sales to Infineon and MicroPort, and has led companies like BioNTech and Immatics to listings on stock exchanges.

MIG Capital is the only retail venture capital investor in Germany, with public funds fully funded by private individuals. The firm is committed to economic, ecological, and social sustainability, aiming to contribute to the development of a viable, healthy society and the preservation of the planet through its investments.